drugset / Trial / NCT06271538
Evaluation of Efficacy of Skål Pro Powder on Symptoms of Irritable Bowel Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this randomized, double-blind, placebo-controlled study is to evaluate the effectiveness of Skal Pro in alleviating symptoms, enhancing stool consistency, improving quality of life, and addressing psychological distress in individuals diagnosed with irritable bowel syndrome (IBS), as compared to those who receive no intervention.
Timeline
- Start
- 2024-10-17
- Primary completion
- 2026-03-31
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactobacillus plantarum 299v | Other / unclassified | 1e+10 unknown | — |
| Subject | galactooligosaccharides | Unknown | — | — |